NTRK2 and cancer: The possibility that Trk receptors are involved in carcinogenesis in tumors derived from embryonal neural crest cells is supported by evidence that constitutive activation of TrkB is sufficient to promote malignant transformation, accompanied by increased expression of MYCN and other cancer-associated genes and reduced expression of tumor suppressor genes, in neural crest cells.